Deserpidine
Catecholamine-depleting Sympatholytic — CARDIOVASCULAR SYSTEM
Also known as: deserpidin, raunormin, raunormine, recanescin, recanescine, reserpidine
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Deserpidine is an ofm drug in the Catecholamine-depleting Sympatholytic class catalogued in DrugCentral. It was first approved by the FDA in 1957. DrugCentral lists 1 molecular target, including SLC18A2.
- Approval status: ofm (first approved 1957 by the FDA).
- Drug class: Catecholamine-depleting Sympatholytic.
- Molecular targets: SLC18A2 (1 listed in DrugCentral).
- ATC code: C02AA05 (Rauwolfia alkaloids).
- Molecular formula: C32H38N2O8; molecular weight 578.66 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Contraindications (26)
- Acute pancreatitis
- Anuria
- Azotemia
- Cirrhosis of liver
- Dehydration
- Diabetes mellitus
- Disease of liver
- Fluid volume disorder
- Gout
- Hepatic coma
- Hypercalcemia
- Hypercholesterolemia
- Hyperparathyroidism
- Hypertriglyceridemia
- Hyperuricemia
- Hypochloremic alkalosis
- Hypokalemia
- Hypomagnesemia
- Hyponatremia
- Hypovolemia
- Impaired renal function disorder
- Neonatal hyperbilirubinemia
- Oliguria
- Secondary angle-closure glaucoma
- Sympathectomy
- Systemic lupus erythematosus
Mechanism & targets
| Established pharmacologic class | Catecholamine-depleting Sympatholytic |
|---|
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Synaptic vesicular amine transporter | SLC18A2 | inhibitor | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1957-04-19 | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C02AA05 | CARDIOVASCULAR SYSTEM › ANTIHYPERTENSIVES › ANTIADRENERGIC AGENTS, CENTRALLY ACTING › Rauwolfia alkaloids |
C02LA03 | CARDIOVASCULAR SYSTEM › ANTIHYPERTENSIVES › ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION › Rauwolfia alkaloids and diuretics in combination |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Deserpidine is on its molecule page.
| Molecular formula | C32H38N2O8 |
|---|---|
| Molecular weight | 578.66 g/mol |
| CAS number | 131-01-1 |
| InChIKey | CVBMAZKKCSYWQR-WCGOZPBSSA-N |
| PubChem CID | 8550 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Deserpidine work?
Its molecular targets in DrugCentral include SLC18A2 (inhibitor).
When was Deserpidine first approved?
Deserpidine was first approved by the FDA in 1957.
What drug class does Deserpidine belong to?
Deserpidine is in the Catecholamine-depleting Sympatholytic class.
What is the chemical formula of Deserpidine?
Deserpidine has the molecular formula C32H38N2O8 and a molecular weight of 578.66 g/mol.
Browse: all drugs starting with D · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 810 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200515 — compound record and bioactivity
- PubChem CID 8550 — chemical identifiers
- DrugBank DB01089 — drug record
- FDA UNII 9016E3VB47 — substance identity
- DailyMed: FDA labels for Deserpidine — current prescribing information (label search)
- UniProt Q05940 (SLC18A2) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.